var Date1 = "2/09/12";
    var Title1 = "Pharmacyclics Reports Fiscal 2012 Second Quarter Financial Results";
    var URL1 = "http://ir.pharmacyclics.com//ReleaseDetail.cfm?ReleaseID=647492";
  
    var Date2 = "12/19/11";
    var Title2 = "Pharmacyclics Inc. Receives Issue Notice of Significant Bruton\'s Tyrosine Kinase (BTK) Patent";
    var URL2 = "http://ir.pharmacyclics.com//ReleaseDetail.cfm?ReleaseID=634117";
  
    var Date3 = "12/13/11";
    var Title3 = "Pharmacyclics® Announces Updated Results for BTK Inhibitor PCI-32765 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma at American Society for Hematology (ASH) Annual Meeting";
    var URL3 = "http://ir.pharmacyclics.com//ReleaseDetail.cfm?ReleaseID=632852";
  
    var Date4 = "12/12/11";
    var Title4 = "Pharmacyclics® Reports Interim Phase II Trial Results for BTK Inhibitor PCI-32765 in Mantle Cell Lymphoma at American Society of Hematology (ASH) Annual Meeting";
    var URL4 = "http://ir.pharmacyclics.com//ReleaseDetail.cfm?ReleaseID=632579";
  
    var Date5 = "12/08/11";
    var Title5 = "Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc.";
    var URL5 = "http://ir.pharmacyclics.com//ReleaseDetail.cfm?ReleaseID=631854";